Physician profile
John Reilly
NPI 1689614133
$1,499.70
in general payments reported to CMS, 2019-2025
20 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $194 · 2022: $118 · 2023: $363 · 2024: $305 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $412.29 | 2019-2024 | Imfinzi |
| Novocure INC. | $188.93 | 2021-2025 | Optune, Optune Gio |
| Bayer Healthcare Pharmaceuticals INC. | $174.46 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $131.88 | 2021-2025 | Prolaris |
| Regeneron Healthcare Solutions, INC. | $121.52 | 2022-2025 | Libtayo |
| Merck Sharp & Dohme LLC | $53.10 | 2024-2025 | Keytruda, Keytruda Qlex |
| Brainlab, INC. | $50.52 | 2022-2025 | Brainlab, INC., Image Guided Surgical Device |
| Elekta, INC. | $47.47 | 2021-2023 | Elekta Medical Linear Accelerator |
| Novartis Pharmaceuticals Corporation | $42.26 | 2025 | |
| Gt Medical Technologies, INC | $36.19 | 2023-2024 | Gammatile, Gammatile |
| Reflexion Medical, INC. | $33.20 | 2024 | Reflexion Medical Radiotherapy System |
| Ambu INC. | $30.94 | 2021 | |
| Boston Scientific Corporation | $28.00 | 2023 | Varithena Administration Pack |
| Blue Earth Diagnostics | $24.90 | 2025 | Posluma |
| Tersera Therapeutics LLC | $23.89 | 2024 | Zoladex |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viewray Technologies INC | $22.35 | 2021 | |
| Pfizer INC. | $21.14 | 2024 | |
| Coherus Oncology, INC. | $19.77 | 2025 | Loqtorzi |
| Teleflex LLC | $18.84 | 2025 | Barrigel |
| Lilly USA, LLC | $18.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.